| Makale Türü | Özgün Makale (SSCI, AHCI, SCI, SCI-Exp dergilerinde yayınlanan tam makale) | ||
| Dergi Adı | Veterinary Clinical Pathology | ||
| Dergi ISSN | 0275-6382 Wos Dergi Scopus Dergi | ||
| Dergi Tarandığı Indeksler | SCI-Expanded | ||
| Makale Dili | İngilizce | Basım Tarihi | 12-2011 |
| Cilt / Sayı / Sayfa | 40 / 4 / 518–523 | DOI | 10.1111/j.1939-165X.2011.00370.x |
| Makale Linki | http://onlinelibrary.wiley.com/enhanced/doi/10.1111/j.1939-165X.2011.00370.x/ | ||
| UAK Araştırma Alanları |
Zootekni, Genetik ve Biyoistatistik
|
||
| Özet |
| Background: Dog erythrocyte antigen (DEA) 1.1 is the most important RBC antigen clinically, as it is highly immunogenic and causes acute hemolytic transfusion reactions (HTR) in sensitized dogs. Objectives: The aims of this study were to determine the frequency of DEA 1.1 expression in 4 Turkish dog breeds, and to estimate the potential risk of HTR when blood from a DEA 1.1-positive donor is administered to a DEA 1.1-negative recipient following sensitization by a prior mismatched transfusion. Methods: EDTA blood samples (n = 178) were typed for DEA 1.1 using a commercial gel-column agglutination test (ID-Gel-Test Canine DEA 1.1). Probabilities of sensitization and risk of an HTR were calculated. Results: The frequency of positivity for DEA 1.1 among Kars (n = 59), Kangal (n = 53), Akbash (n = 50), and Catalburun (n = 16) breeds was 71.2%, 67.9%, 60.0%, and 50.0%, respectively. Potential risk for occurrence of an HTR after administration of blood from a dog of the same breed ranged from 12.5% to 14.8%, whereas HTR induced by blood of a dog from a different breed ranged from 7.2% to 25.3%. Conclusions: The frequency of DEA 1.1-positive dogs among 4 Turkish breeds is high compared with that of most other breeds previously surveyed. The predicted risk of both sensitization and occurrence of DEA 1.1-related HTR following transfusion between dogs of either the same or different Turkish breeds was considerable. Although few dogs are transfused ≥4 days after the first transfusion, we recommend that (1) all donors and recipients be typed for DEA 1.1, (2) DEA 1.1-negative recipients receive only DEA 1.1-negative blood, and (3) blood be cross-matched prior to transfusing any dog ≥4 days after the first transfusion. These guidelines are also applicable to other breeds and countries. © 2011 American Society for Veterinary Clinical Pathology. |
| Anahtar Kelimeler |
| Blood type | DEA | Hemolytic reaction | Sensitization | Transfusion medicine |
| Atıf Sayıları | |
| Web of Science | 16 |
| Scopus | 20 |
| Dergi Adı | VETERINARY CLINICAL PATHOLOGY |
| Yayıncı | Wiley-Blackwell |
| Açık Erişim | Hayır |
| ISSN | 0275-6382 |
| E-ISSN | 1939-165X |
| CiteScore | 2,0 |
| SJR | 0,462 |
| SNIP | 0,768 |